Formation Bio

Last month, our team gathered from near and far for our company retreat in New Jersey to connect, reflect, and reinforce our mission to transform drug development using AI. We celebrated our milestones from 2024, sharpened our focus for an impactful 2025, and explored what sets us apart as a company. And, of course, enjoyed tons of fun activities like foot golf, a foraging hike, s'mores & more! If you’re interested in joining our growing team of pharma and tech talent driving the future of pharma innovation, check out our open roles: https://lnkd.in/eH8HnnsW.

It was our pleasure to present to a packed house at Bloomberg's "AI in Drug Development" forum last week in NYC, where speakers from companies from across the lifecycle of drug development (ranging from pre-clinical to post-approval) gathered to discuss AI's transformative impact on the pharmaceutical industry. There is still much work ahead, but the potential - short and long term - to transform the industry with AI and deliver new treatments to patients faster and more efficiently is unmistakably clear. Photo of Gavin Corcoran, MD FACP, courtesy of Bloomberg. Generate:Biomedicines, Owkin, Certara, Clario, Flagship Pioneering, Insilico Medicine Parexel #drugdevelopment #ai #pharma #clinicaldevelopment #artificialintelligence #nyc #biotech #techbio

We're thrilled to have Benjamine Liu honored alongside so many incredible innovators in the industry in this 50 under 50 in Healthcare award presented by Slice of Healthcare and Microsoft! Interested in joining our team? Check out our open roles: https://lnkd.in/eVsCezpp

We're delighted to have contributed to this white paper published today by the World Economic Forum and ZS exploring AI’s potential to revolutionize clinical development. The themes explored in this paper align deeply with our mission to harness AI for transformative advances in drug development, working to ultimately bring new treatments to patients faster and more efficiently. https://lnkd.in/dkdvHVPU #drugdevelopment #clinicaldevelopment #ai #genai #clinicaltrials #pharma #biotech Gavin Corcoran, MD FACP

Our Chief Development Officer, Gavin Corcoran, MD FACP will be presenting on AI in Clinical Development as part of Bloomberg's AI & Drug Development Forum taking place next week in NYC! Learn more and register to attend here. https://lnkd.in/eE2x9E8M Other companies presenting include: Generate:Biomedicines, Owkin, Certara, Clario, Flagship Pioneering, Insilico Medicine and Parexel. We hope to see you there! #drugdevelopment #ai #pharma #clinicaldevelopment #artificialintelligence #nyc #biotech #techbio

https://lnkd.in/eMsBJSFV

What if we could identify the right patients for our research and development programs in just a matter of minutes?  When Sanofi announced our collaboration with Formation Bio and OpenAI five months ago, I knew good things were coming. Already we are making tangible progress with the introduction of Muse - a first-of-its kind AI powered tool to optimize patient recruitment for clinical trials.  Patients are at the center of all our research and development programs. Without them, we would not be able to turn scientific discoveries into best-in-class medicines and vaccines that improve lives. Muse will give us access to a wider, diverse pool of potential participants so we can more precisely identify the right patients for our research. It’s the perfect example of what we can accomplish by combining the strengths of like-minded partners who see the power of AI in shaping the future of drug development.  Muse is another building block in our ambition to be the first pharma company powered by AI at scale – and the first in a growing pipeline of innovations being created to help us accelerate drug development so we can deliver medical breakthroughs for people around the world.  Learn more about Muse here: https://lnkd.in/e5wfX_WU #AI #innovation #immunoscience 

AI systems are beginning to become capable of performing tasks that once required entire teams or organizations. This will have profound impact for pharma, enabling our industry to drastically reduce the cost and time of drug development.

Today we announced Muse, our AI tool for patient recruitment strategy & content creation, built in collaboration with Sanofi and OpenAI. Muse is an example of how AI systems are beginning to become capable of performing tasks that once required entire teams or organizations. We believe AI systems like Muse, applied across all drug development processes, will enable us to drastically reduce the cost and time of bringing new medicines to patients. Read more here. https://lnkd.in/eubrhH_w #ai #drugdevelopment #clinicaldevelopment #pharma #biotech #clinicaltrials

We'll be presenting at PHUSE EU Connect next week! We'll be sharing some of the ways we're using AI to make drug development more efficient to ultimately bring new treatments to patients faster. Hope to see you there! Also - we're hiring! Check out our open roles here: https://lnkd.in/eH8HnnsW #datascience #ai #drugdevelopment #clinicaltrials #biotech #pharma #conferences #analytics #clinicaldevelopment Emily (Murphy) Yates Melanie Hullings